SenesTech Announces Record Second Quarter 2022 Product Sales

Sales up 73% year-over-year and up 42% sequentially PHOENIX, Aug. 11, 2022 /PRNewswire/ — SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female…

Leave a Reply

Your email address will not be published. Required fields are marked *